Industry
Healthcare and life sciences with a focus on USA, Canada and India.
A representative healthcare and life sciences scenario showing how cybersecurity and resilience can improve regulated supply, product integrity, clinical service, evidence and data quality.
Helping your business enhance Customer Experience Ownership so it runs better, faster and cheaper, without the nonsense.
A representative healthcare and life sciences scenario showing how cybersecurity and resilience can improve regulated supply, product integrity, clinical service, evidence and data quality. This narrative is organized for executive discovery and should be validated against the relevant business baseline before it is used as a quantified customer claim.
Each capability is stronger when it is connected to the process, data and operating model around it.
Healthcare and life sciences with a focus on USA, Canada and India.
Access risk, recovery uncertainty and fragmented ownership weakened confidence in critical operations. The leadership team also needed a more dependable view of regulated supply, product integrity, clinical service, evidence and data quality before committing to the next investment.
Role design, SoD controls, privileged access, monitoring, backup and recovery runbooks were brought into one model. The solution included executive baseline definition, role ownership, delivery evidence and a post-go-live review rhythm.
Illustrative planning range: 25 to 40% faster access review and materially lower recovery uncertainty. This is planning content for discovery and should be recalculated from actual process, cost, carbon and service baselines.
the COO, CIO and quality leadership can use the scenario to connect the investment to cash, risk, customer experience, carbon performance and operating capacity.
A representative healthcare and life sciences scenario showing how cybersecurity and resilience can improve regulated supply, product integrity, clinical service, evidence and data quality.
USA, Canada and India
Access risk, recovery uncertainty and fragmented ownership weakened confidence in critical operations. The leadership team also needed a more dependable view of regulated supply, product integrity, clinical service, evidence and data quality before committing to the next investment.
Role design, SoD controls, privileged access, monitoring, backup and recovery runbooks were brought into one model. The solution included executive baseline definition, role ownership, delivery evidence and a post-go-live review rhythm.
Illustrative planning range: 25 to 40% faster access review and materially lower recovery uncertainty. This is planning content for discovery and should be recalculated from actual process, cost, carbon and service baselines.
the COO, CIO and quality leadership can use the scenario to connect the investment to cash, risk, customer experience, carbon performance and operating capacity.